Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI

NCT04483583 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Ticagrelor 60mg
DRUG: Clopidogrel

Sponsor

University of Florida